相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。QuantiFERON®-TB Gold In-Tube test can be used for screening latent tuberculosis before biological treatment in a Bacille Calmette-Guerin (BCG)-vaccinated country: the HUR-BIO single-center real-life results
Emrah Seyhoglu et al.
CLINICAL RHEUMATOLOGY (2021)
Superiority of Interferon Gamma Assay Over Tuberculin Skin Test for Latent Tuberculosis in Inflammatory Bowel Disease Patients in Brazil
Renata F. Amorim et al.
DIGESTIVE DISEASES AND SCIENCES (2019)
Serial Tuberculin Skin Tests Improve the Detection of Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease
Carlos Taxonera et al.
JOURNAL OF CROHNS & COLITIS (2018)
Early Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease
Carlos Taxonera et al.
JOURNAL OF CROHNS & COLITIS (2017)
The impact of immunosuppressive therapy on QuantiFERON and tuberculin skin test for screening of latent tuberculosis in patients with inflammatory bowel disease scheduled for anti-TNF therapy
Gerassimos J. Mantzaris et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2015)
Increased incidence of liver enzymes abnormalities in patients treated with isoniazid in combination with disease modifying and/or biologic agents
Josiane Bourre-Tessier et al.
CLINICAL RHEUMATOLOGY (2014)
Diagnosis of Latent Tuberculosis in Patients with Systemic Lupus Erythematosus: T.SPOT.TB versus Tuberculin Skin Test
Maria Del Mar Arenas Miras et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Prophylaxis for Latent Tuberculosis Infection Prior to Anti-Tumor Necrosis Factor Therapy in Low-Risk Elderly Patients With Rheumatoid Arthritis: A Decision Analysis
Glen S. Hazlewood et al.
ARTHRITIS CARE & RESEARCH (2013)
Discordance among Commercially Available Diagnostics for Latent Tuberculosis Infection
James D. Mancuso et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Interferon-γ release assay versus tuberculin skin test prior to treatment with golimumab, a human anti-tumor necrosis factor antibody, in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis
Elizabeth C. Hsia et al.
ARTHRITIS AND RHEUMATISM (2012)
Canadian Rheumatology Association Recommendations for the Pharmacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic Drugs: Part II Safety
Claire Bombardier et al.
JOURNAL OF RHEUMATOLOGY (2012)
2012 Update of the 2008 American College of Rheumatology Recommendations for the Use of Disease-Modifying Antirheumatic Drugs and Biologic Agents in the Treatment of Rheumatoid Arthritis
Jasvinder A. Singh et al.
ARTHRITIS CARE & RESEARCH (2012)
Quantiferon-TB Gold in tube assay for the screening of tuberculosis before and during treatment with tumor necrosis factor alpha antagonists
Gulen Hatemi et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Prednisolone Treatment Affects the Performance of the QuantiFERON Gold In-Tube Test and the Tuberculin Skin Test in Patients with Autoimmune Disorders Screened for Latent Tuberculosis Infection
Erika Belard et al.
INFLAMMATORY BOWEL DISEASES (2011)
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement
I. Solovic et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Comparison of interferon-Y release assay and tuberculin test for screening in healthcare workers
Jose Torres Costa et al.
REVISTA PORTUGUESA DE PNEUMOLOGIA (2010)
Prevalence of positive ppd in a cohort of rheumatoid arthritis patients
Maria Natalia Tamborenea et al.
RHEUMATOLOGY INTERNATIONAL (2010)
QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases
F. Bartalesi et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Screening for tuberculosis infection prior to initiation of anti-TNF therapy
Ajit Lalvani et al.
AUTOIMMUNITY REVIEWS (2008)
An official ATS statement: Hepatotoxicity of antituberculosis therapy
Jussi J. Saukkonen et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-α treatment
LP Ormerod et al.
THORAX (2005)
TNF-blocking agents and tuberculosis: new drugs illuminate an old topic
J Keane
RHEUMATOLOGY (2005)
Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists
L Carmona et al.
ARTHRITIS AND RHEUMATISM (2005)
Granulomatous infections due to tumor necrosis factor blockade: Correction
RS Wallis et al.
CLINICAL INFECTIOUS DISEASES (2004)
Granulomatous infectious diseases associated with tumor necrosis factor antagonists
RS Wallis et al.
CLINICAL INFECTIOUS DISEASES (2004)
Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk -: A multicenter active-surveillance report
JJ Gómez-Reino et al.
ARTHRITIS AND RHEUMATISM (2003)
High incidence of hepatotoxicity of isoniazid treatment for tuberculosis chemoprophylaxis in patients with rheumatoid arthritis treated with methotrexate or sulfasalazine and antitumour necrosis factor inhibitors
J Vanhoof et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurements
L Wang et al.
THORAX (2002)
Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent
J Keane et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Comparison of a whole-blood interferon γ assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection
GH Mazurek et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Infliximab and methotrexate in the treatment of rheumatoid arthritis
PE Lipsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
